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Aims Dynamic three-dimensional-cardiac magnetic resonance (3D-CMR) perfusion proved highly diagnostic for the detec-
tion of angiographically defined coronary artery disease (CAD) and has been used to assess the efficacy of coronary
stenting procedures. The present study aimed to relate significant coronary lesions as assessed by fractional flow
reserve (FFR) to the volume of myocardial hypoenhancement on 3D-CMR adenosine stress perfusion imaging and
to define the inter-study reproducibility of stress inducible 3D-CMR hypoperfusion.
Methods
and results
A total of 120 patients with known or suspected CAD were examined in two CMR centres using 1.5 T systems. The
protocol included cine imaging, 3D-CMR perfusion during adenosine infusion, and at rest followed by delayed en-
hancement (DE) imaging. Fractional flow reserve was recorded in epicardial coronary arteries and side branches
with ≥2 mm luminal diameter and .40% severity stenosis (pathologic FFR, 0.75). Twenty-five patients underwent
an identical repeat CMR examination for the determination of inter-study reproducibility of 3D-CMR perfusion def-
icits induced by adenosine. Three-dimensional CMR perfusion scans were visually classified as pathologic if one or
more segments showed an inducible perfusion deficit in the absence of DE. Myocardial ischaemic burden (MIB)
was measured by segmentation of the area of inducible hypoenhancement and normalized to left ventricular myo-
cardial volume (MIB, %). Three-dimensional CMR perfusion resulted in a sensitivity, specificity, and diagnostic accur-
acy of 90, 82, and 87%, respectively. Substantial concordance was found for inter-study reproducibility [Lin’s
correlation coefficient: 0.98 (95% confidence interval: 0.96–0.99)].
Conclusion Three-dimensional CMR stress perfusion provided high diagnostic accuracy for the detection of functionally signifi-
cant CAD. Myocardial ischaemic burden measurements were highly reproducible and allowed the assessment of
CAD severity.
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Introduction
Cardiac magnetic resonance (CMR) imaging enables non-invasive
assessment of myocardial perfusion in patients with known and
suspected coronary artery disease (CAD).1–5 Two-dimensional
multislice CMR perfusion techniques yield high diagnostic accuracy,
but the limited spatial coverage does not permit quantification of
ischaemic tissue volume to guide therapy as recommended by
the recent European guidelines on myocardial revascularization.6
Therefore, radiation-based nuclear imaging methods have become
the methods of choice for quantifying ventricular ischaemia.7,8
Besides exposure of the patient with ionizing radiation, the limited
spatial resolution provided by single photon and positron emission
tomography may be regarded as a drawback particularly when
aiming at the detection of subendocardial ischaemic reactions.
In order to address the limited, non-contiguous coverage of
two-dimensional, multislice CMR perfusion techniques, three-
dimensional (3D-CMR) methods have been developed.9–11
Whole-heart coverage is achieved by employing data under sam-
pling strategies in conjunction with appropriate image reconstruc-
tion techniques.12 In a particular implementation, dynamic
3D-CMR perfusion imaging utilizes under-sampling in k-space and
time (k-t) including sensitivity encoding (SENSE).11,13,14 This ap-
proach proved highly diagnostic for the detection of angiographi-
cally defined CAD based on quantitative angiographic
measurements and has been successfully employed to assess the
efficacy of coronary stenting procedures using volumetry of myo-
cardial hypoenhancement.15 However, quantitative coronary angi-
ography (QCA) is of limited value for the characterization of the
functional severity of coronary artery narrowing especially at inter-
mediate degrees of stenosis and thus has been recognized as a
poor indicator of functionally significant CAD when compared
with pressure-derived fractional flow reserve (FFR).16,17
Consequently, the objectives of the present dual-centre study
were: (i) to evaluate the diagnostic performance of dynamic
3D-CMR perfusion for the detection of functionally significant
CAD as defined by FFR, (ii) to relate the volume of myocardial
hypoenhancement to the extent and anatomical localization of
the disease, and (iii) to assess the inter-study reproducibility of
stress inducible 3D-CMR hypoperfusion.
Methods
Study population
The present prospective study was conducted at two centres (Univer-
sity Hospital Zurich, Switzerland, and University Hospital RWTH
Aachen, Germany). A total of 120 patients (n ¼ 31 from Zurich, n ¼
89 from Aachen; n ¼ 90 males; mean age 63.7+ 11.9 years, range
42–90 years) scheduled for diagnostic coronary angiography for the
evaluation of known or suspected CAD, but without prior coronary
bypass grafting, were consecutively recruited between July 2010 and
January 2011. All patients gave written informed consent and the
study was approved by the local ethics review boards. Patients were
instructed to refrain from caffeine-containing substances 24 h prior to
the examination. Patients were not considered for study inclusion if
they had typical contraindications for CMR imaging (e.g. incompatible
metallic implants and claustrophobia) or administration of adenosine.
In a subgroup of 25 patients, a repeat stress 3D-CMR perfusion
examination was performed within 24 h prior to invasive coronary
angiography to assess inter-study reproducibility.
Cardiac magnetic resonance study
Cardiac magnetic resonance imaging was performed with the patient in
the supine position using a 1.5 T MR scanner (Philips Achieva, Best,
The Netherlands). A five-element cardiac synergy coil was used for
signal reception and cardiac synchronization was performed with a
vector-ECG.
After the acquisition of standard cine scans for the assessment of left
ventricular function, 3D-CMR perfusion imaging data were acquired.
Adenosine was administered intravenously at a dose of 140 mg/kg/
min under continuous monitoring of heart rate and blood pressure.
After at least 3 min of adenosine infusion, 3D-CMR stress first-pass
perfusion imaging (i.v. bolus application of 0.1 mmol/kg of a
gadolinium-based contrast agent, Magnevist Bayer Schering, Berlin,
Germany; injection rate 4.0 mL/s followed by 20 mL saline flush) was
performed in short-axis geometry with full left ventricular coverage.
After a 10 min waiting period for equilibration of the contrast agent
within the myocardium, the identical 3D-CMR perfusion scan was
repeated at rest. Finally, following another 10 min waiting period,
delayed enhancement (DE) imaging was done in the identical short-
axis geometry with a 3D inversion prepared spoiled gradient-echo
sequence.
Three-dimensional cardiac magnetic
resonance perfusion imaging technique
The perfusion imaging protocol consisted of a saturation-recovery
gradient-echo pulse sequence (TR/TE/flip angle 1.9 ms/0.8 ms/158, sat-
uration prepulse delay 150 ms, partial Fourier acquisition, FOV 350 ×
350 mm, measured voxel size 2.3 × 2.3 × 10.0 mm3 reconstructed to
2.0 × 2.0× × 5.0 mm3, number of slices 16). Ten-fold data undersam-
pling was employed resulting in a net seven-fold acceleration relative to
standard CMR imaging techniques, thereby permitting acquisition of a
volume with 16 slices of 5.0 mm thickness each in every heartbeat.11
Visual assessment of dynamic
three-dimensional cardiac magnetic
resonance perfusion scans
Cardiac magnetic resonance examinations were analysed visually by a
single observer fully blinded to clinical and angiographic patient data on
a dedicated workstation (Extended Work Space, Philips Medical
Systems). All short-axis slices with clearly identifiable left ventricular
cavity enhancement during contrast agent first-pass and with .75%
circumferential left ventricular myocardium were selected. The short-
axis slices were divided into six equally distributed segments and
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evaluated visually. Perfusion defects in any segment with ≥25% trans-
murality persisting for three or more consecutive dynamics not being
visible on the rest perfusion scan and in the absence of DE were con-
sidered to be pathologic.
Measurement of myocardial ischaemic
burden
Quantification of myocardial hypoenhancement was performed in all
patients using GT Volume (version 1.3.16, GyroTools, Zurich,
Switzerland). For the determination of myocardial hypoenhancement,
the single dynamic slice images of the stress perfusion scan showing the
maximum extent of regional hypoenhancement during peak signal en-
hancement of remote myocardium were chosen. In the presence of
extensive ischaemia-related hypoenhancement (e.g. high-grade triple-
vessel disease), the remote myocardium either represented an entire
myocardial segment or its subepicardial layer. The observer manually
traced left ventricular endo- and epicardial borders in all slices.
Segmentation of the left ventricular myocardium was done on a
pixel-by-pixel basis by adjusting the signal intensity threshold of .2
standard deviations (SD) below the signal of the remote myocardium,
and the area of hypoenhancement was measured. Volumes of total left
ventricular myocardium and total myocardial hypoenhancement were
calculated using the disk summation method. Myocardial ischaemic
burden (MIB) was defined by the volume of hypoenhancement nor-
malized to total left ventricular myocardial volume and expressed in
per cent.
In the presence of myocardial scar, the amount was quantified on
DE images by manual segmentation based on a signal intensity thresh-
old of .2 SD above the average signal of the remote myocardium and
subtracted from the volume of hypoenhancement.
Inter-study reproducibility
In 25 randomly chosen patients, 3D-CMR perfusion imaging was per-
formed twice prior to invasive coronary angiography for the determin-
ation of inter-study reproducibility. Evaluation of MIB of repeat
examinations was conducted by the same reader following a time
period of ≥4 weeks with the reader being fully blinded to clinical
and angiographic patient data.
Fractional flow reserve measurements
and quantitative coronary angiography
Coronary angiography was performed by standard techniques. At least
two orthogonal views of every major coronary vessel and its side
branches were acquired. QCA (Philips Inturis CardioView, QCA V3.3,
Pie Medical Imaging) was performed off-line by an independent observer
being unaware of the results of CMR imaging. FFR was measured using
standard methods17 with a 0.014 in. coronary pressure sensor-tip wire
(Volcano Therapeutics, San Diego, CA, USA, and Pressure-Wire
Certus, St Jude Medical Systems AB, Uppsala, Sweden) in all vessels
with a ≥40% diameter stenosis in two orthogonal views in vessels with
≥2 mm luminal diameter. For the purposes of the study, smaller diameter
stenoses were considered non-significant. Coronary lesions with an FFR
value of ,0.75 were classified as haemodynamically relevant. Total
or subtotal vessel occlusions were assigned an FFR value of 0.5.
Statistical analysis
Statistical data analysis was performed using SPSS for Windows 17.0.0
(2008, Chicago, IL, USA). Continuous variables are expressed as
mean+ SD; categorical variables are expressed as proportions. The
paired Student’s t-test was used to assess statistical significance of con-
tinuous variables between rest and stress. All tests were two tailed;
P, 0.05 was considered significant. To determine the cut-off value
of MIB being predictive of the presence or absence of significant cor-
onary artery disease as defined by FFR, 0.75, receiver-operator char-
acteristic (ROC) curve analysis was performed and the area under the
curve was calculated. Sensitivity and specificity with corresponding
95% confidence intervals (95% CI) were calculated according to stand-
ard definitions. In addition, the Bland–Altman analysis was carried out
to assess the inter-study reproducibility. To address clustering of ter-
ritories within patients, linear regressions with MIB as a dependent
variable and robust standard error with patient ID as a cluster were
performed. Independent variables were dummy variables for ischaemic
vs. non-ischaemic territories and for distal, medial, proximal, and side
branch territory, respectively, Stata 11.2 (StataCorp, College Station,
TX, USA) was used.
Results
Patient characteristics
All 120 patients successfully completed the CMR protocol and the
invasive procedures and constituted the final population for data
analysis. Tables 1 and 2 provide the clinical baseline characteristics
of the patient population and the haemodynamic data recorded
during the CMR examination, respectively.
Diagnostic performance
The prevalence of CAD as defined by FFR, 0.75 was 57.5% (69
of 120 patients). Fifty-three patients had single-vessel disease,
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Table 1 Patient demographics and clinical data
Parameter n5 120 patients
Male, n (%) 90 (75)
Age (years) 63.7+11.9
Range 42–90
BMI (kg/m2) 27.0+3.4
Cardiovascular risk factors, n (%)
Arterial hypertension 87 (72.5)
Diabetes mellitus 31 (25.8)
Hyperlipoproteinaemia 68 (56.7)
Smoking 53 (44.2)
Family history of CAD 33 (27.5)
Coronary artery disease
Known CAD 66 (55.0)
Single-vessel diseasea 53 (44.2)
Multi-vessel diseasea 16 (13.3)
Left ventricular function
LVEF (%) 54.8+9.8
LVEDV (mL) 157.4+55.9
LVESV (mL) 74.4+48.0
Data are n (%) or mean+ SD. BMI, body mass index; CAD, coronary artery
disease; LVEF, left ventricular ejection fraction; LVEDV, left ventricular
end-diastolic volume; LVESV, left ventricular end-systolic volume.
aDefined by fractional flow reserve ,0.75.
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11 patients had double-vessel disease, and 5 patients had triple-
vessel disease. Visual analysis of 3D-CMR perfusion on a per-
patient basis yielded a sensitivity of 90% [95% confidence interval
(CI): 82–98], specificity of 82% (95% CI: 71–94), and diagnostic
accuracy of 87% (95% CI: 80–93). For the detection of single-
and multi- (i.e. double and triple) vessel disease, sensitivity was
89% (47 of 53) and 94% (15 of 16), respectively.
The prevalence of CAD as defined by QCA ≥ 50% was 54.2%
(65 of 120 patients). Visual analysis of 3D-CMR perfusion on a per-
patient basis with QCA as the reference standard yielded a sensi-
tivity of 88% (95% CI: 77–95), specificity of 75% (95% CI: 61–83),
and diagnostic accuracy of 81% (95% CI: 73–88).
Representative CMR imaging examples are shown in Figures 1–3
with corresponding movie files (see Supplementary material
online, Movies S1–S5).
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Table 2 Haemodynamic parameters
Parameter n 5 120 patients
Heart rate (b.p.m.)
At rest 68.1+10.9
Adenosine stress 84.1+14.8*
Systolic blood pressure (mmHg)
At rest 130.2+21.7
Adenosine stress 127.7+20.3
Heart rate pressure product (b.p.m. × mmHg)
At rest 8904+2311
Adenosine stress 10780+2812*
Data are mean+ SD.
*P, 0.001 for rest vs. stress (paired Student’s t-test).
Figure 1 (A) Three-dimensional cardiac magnetic resonance perfusion scans during adenosine stress (a) and at rest (b). A strictly inducible
perfusion deficit in anterior/anteroseptal segments extending from apical to mid-ventricular slices can be clearly delineated (myocardial ischae-
mic burden 18.8% of the left ventricular myocardium). Invasive X-ray coronary angiogram (c and d) demonstrated high-grade single-vessel
disease with subtotal occlusion of the left anterior descending artery (LAD; see also Supplementary material online, Movies S1–S3). (B) Three-
dimensional delayed enhancement cardiac magnetic resonance imaging proved the absence of myocardial scar tissue.
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Assessment of myocardial ischaemic
burden
In all patients MIB averaged to 13.8+17.2% (range, 0–79.2%). The
mean MIB per coronary territory with and without haemodynam-
ically significant stenosis as defined by FFR is displayed in Figure 4A.
The relation between lesion localization within the coronary arter-
ial tree (i.e. proximal, medial, distal, or side branch stenosis) and
the corresponding amount of MIB is illustrated in Figure 4B and
confirmed the gradual increase in MIB with more proximal lesion
location.
Figure 2 (A) Three-dimensional cardiac magnetic resonance perfusion scans during adenosine stress (a) and at rest (b). An extensive indu-
cible perfusion deficit in the anterior/anteroseptal and inferolateral segments can be appreciated (myocardial ischaemic burden 33.6% of the left
ventricular myocardium). Invasive X-ray coronary angiogram demonstrated a double-vessel disease of the left anterior descending artery (LAD,
c) with a fractional flow reserve (FFR) of 0.73 and the intermediate branch (d) with an FFR value of 0.46 (see also Supplementary material
online, Movie S4). (B) Three-dimensional delayed enhancement cardiac magnetic resonance imaging proved the absence of myocardial scar
tissue.
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In order to identify the amount of MIB leading to most accurate
identification of FFR-defined coronary artery disease, ROC analysis
was carried out and revealed an MIB cut-off value of 4.4% with a
sensitivity and specificity of 85.5 and 86.3%, respectively (Figure 5).
Inter-study reproducibility of myocardial
ischaemic burden
Inter-study reproducibility of MIB measurements showed a high
correlation (Pearson’s correlation coefficient, 0.98, P, 0.0001)
and substantial concordance [Lin’s correlation coefficient, 0.98
(95% CI: 0.96–0.99)]. The Bland–Altman plot is shown in
Figure 6; the mean bias for inter-study measurements was 3.0+
1.4% (95% CI: 2.4–3.6).
Figure 7 shows a representative imaging example for first and
repeat 3D-CMR examinations.
Discussion
The present study evaluated the diagnostic performance and inter-
study reproducibility of 3D-CMR perfusion for the detection of
functionally significant CAD as defined by FFR measurements.
The main findings of the study were as follows: (i) 3D-CMR perfu-
sion imaging at 1.5 T was successfully performed in a large, con-
secutive patient population in two independent cardiology
departments; (ii) the diagnostic accuracy of 3D-CMR perfusion
imaging was high and within the range of previously published
data on 2D multislice CMR perfusion imaging using FFR as the
Figure 3 (A) Three-dimensional cardiac magnetic resonance perfusion scans during adenosine stress (a) and at rest (b). An extensive indu-
cible perfusion deficit in the anterior/anteroseptal/anterolateral and in the inferior/inferoseptal/inferolateral segments can be appreciated (myo-
cardial ischaemic burden 79.2% of the left ventricular myocardium). Invasive X-ray coronary angiogram demonstrated high-grade left main (LM,
c) and right coronary artery (RCA, d) stenoses (see Supplementary material online, Movie S5). (B) Three-dimensional delayed enhancement
cardiac magnetic resonance imaging proved the presence of subendocardial scar tissue in basal inferior segments only (white arrows).
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reference standard18–20; (iii) the diagnostic accuracy was equally
high in patients with single- and multi-vessel coronary artery
disease; (iv) the amount of MIB gradually increased with more
proximal anatomical localization of coronary lesions; and (v) MIB
measurement showed high inter-study reproducibility.
The present dual-centre 3D-CMR perfusion study with FFR as
the standard of reference yielded similar sensitivity but improved
specificity (90 vs. 92% and 82 vs. 74%, respectively) compared
with previously published data on 3D-CMR perfusion using angio-
graphic stenosis quantification as the standard of reference.15 The
improved specificity may have been due to a lower rate of false-
positive examinations of intermediate degrees of coronary luminal
narrowing on QCA, which are not functionally flow limiting.
The diagnostic performance of 3D-CMR perfusion encountered
in the current study was similar to previous smaller single-centre
studies comparing conventional20 and high-resolution18 2D multi-
slice CMR perfusion against FFR measurements (reported sensitiv-
ity of 91 and 82% and specificity of 94 and 94%, respectively).
Figure 4 (A) Error bar charts of myocardial ischaemic burden (MIB) per coronary territory showing the mean values and corresponding 95%
confidence intervals for coronary arteries with and without haemodynamically significant stenosis as defined by fractional flow reserve. Differ-
ences between groups were statistically significant (P, 0.001). (B) Error bar charts of myocardial ischaemic burden per coronary territory
according to the location of a haemodynamically significant stenosis in the coronary arterial tree as defined by fractional flow reserve. Differ-
ences between groups were statistically significant (P, 0.001).
Figure 5 Receiver-operator characteristic analysis to deter-
mine the cut-off value of myocardial ischaemic burden being pre-
dictive of the presence or absence of significant coronary artery
disease as defined by fractional flow reserve ,0.75. A cut-off
value of myocardial ischaemic burden ¼ 4.4% resulted in a sensi-
tivity and specificity of 85.5 and 86.3%, respectively. AUC, area
under the curve.
Figure 6 The Bland–Altman plot demonstrating the agree-
ment of volumetric myocardial ischemic burden (MIB) measure-
ments in the same patient. In each plot, the central horizontal
line (solid) indicates the mean absolute difference; upper and
lower lines (dashed) represent the 95% confidence intervals.
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A key advantage of 3D-CMR perfusion imaging over 2D acquisi-
tion techniques relates to the volumetric assessment of MIB with a
high inter- and intra-reader reproducibility.15 The high inter-study
reproducibility of 3D-CMR perfusion demonstrated in the present
study further corroborated its robustness and clinical potential to
monitor disease progression or the effectiveness of anti-ischaemic
therapeutic strategies. Of note, the inter-study reproducibility of
MIB was within the range of previously published data on
nuclear perfusion imaging (3.0 vs. 7.2%).21 In addition, the high re-
producibility may result in a lower number of patients needed to
achieve sufficient statistical power in anti-ischaemic trials.22
According to the current guidelines, the decision to perform
coronary revascularization procedures should be based on an ob-
jective documentation of myocardial ischaemia preferably together
with its anatomical localization and amount. Three-dimensional
CMR perfusion imaging proved useful to derive such information
since MIB and coronary stenosis localization/distribution were
readily available. Knowingly, proximal coronary artery disease
confers a worse cardiac prognosis. In addition, the amount of myo-
cardial ischaemia has been successfully employed to guide treat-
ment decisions: revascularization has been recommended in the
case of an MIB exceeding 10%6 of the total left ventricular myocar-
dium, but these cut-off values were derived from myocardial
nuclear studies.7,8 Whether a similar cut-off value may apply to
3D-CMR perfusion imaging is currently unknown and shall be
addressed in future studies.
Recently, the invasive assessment of the functional significance of
coronary lesions has become the cornerstone of therapeutic
decision-making,23,24 though FFR measurements are invasive, time-
consuming, and associated with radiation exposure rendering the
method less attractive for serial assessments.
Finally, 3D-CMR perfusion imaging may be considered a non-
invasive approach to stratify patients according to guidelines
before coronary angiography and therefore might reduce unneces-
sary invasive diagnostic examinations.
Study limitations
Myocardial ischaemic burden as defined by 3D-CMR perfusion
does not provide a measure of quantitative myocardial blood
flow but rather represents a snapshot of relative myocardial perfu-
sion distribution at a specific time point during a dynamic perfusion
measurement. Consequently, MIB needs to be considered a volu-
metric measure of per cent ischaemic myocardium in the individual
patient and, thus, may be used to assist in adequate treatment se-
lection as recommended by the current guidelines on myocardial
revascularization.6
We found that multi-vessel disease was reliably detected by
3D-CMR stress perfusion which mainly resulted from the inherent-
ly high in-plane spatial resolution of the applied 3D-CMR perfusion
technique: an overall myocardial signal suppression (so-called
‘balanced ischemia’) as reported for scintigraphic techniques was
not encountered. However, taking into account the relatively
low prevalence of multi-vessel disease in the current patient popu-
lation (13 and 4% for multi- and triple-vessel disease, respectively),
future studies are necessary to further research and corroborate
this observation.
Finally, in line with the current guidelines and in order to minim-
ize complications of FFR measurements, haemodynamic assess-
ments were only performed in vessels with luminal stenosis of
greater than 40% at angiography.
Conclusion
Three-dimensional CMR stress perfusion imaging proved to be
highly accurate and reproducible in the evaluation of functionally
significant coronary artery disease as defined by FFR. Consequent-
ly, 3D-CMR stress perfusion imaging may be regarded as a clinically
useful, non-invasive diagnostic tool for stratification of patients
with suspected and known coronary artery disease based on the
assessment of MIB and lesion localization.
Figure 7 Three-dimensional cardiac magnetic resonance adenosine stress perfusion scans during the first and second examination of the
same patient for determination of inter-study reproducibility: identical extent of inducible perfusion deficits in anterior/anteroseptal and infer-
olateral segments can be appreciated (myocardial ischaemic burden of first vs. second examination amounted to 33.6 and 30.2%, respectively).
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Supplementary material is available at European Heart Journal
online.
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